Diclofenac Epolamine System
Product Images NDC 80425-0403

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Diclofenac Epolamine (NDC 80425-0403). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Diclofenac Epolamine 1.3% Topical System (Diclofenac Epolamine 1.3 Topical System 80425 0403 01)

Label for Diclofenac Epolamine 1.3% topical system, strength 0.013 g per unit, packaged and labeled by Advanced Rx Pharmacy of Tennessee, LLC, Nashville, TN. The label includes storage instructions (20°-25°C), a barcode, NDC 80425-0403-01, and a lot number with expiration date 4/17/2026. The product is prescription only.*

FDA Label Image

Chemical Structure (Diclofenac 01)

Chemical structure diagram of Diclofenac Epolamine, showing the detailed molecular structure of diclofenac and the epolamine moiety, including functional groups and atomic connections, labeled with chemical names and descriptions.*

FDA Label Image

Figure 1 (Diclofenac 02)

A line graph comparing percent improvement from baseline (x-axis) with percent of patients improved (y-axis) for Diclofenac Patch versus Placebo groups. Two lines show higher patient improvement percentages for Diclofenac Patch compared to Placebo across measured improvement percentages.*

FDA Label Image

Figure 2 (Diclofenac 03)

A line graph comparing the percent of patients improved versus percent improvement from baseline for Diclofenac Patch and Placebo. The graph shows two trend lines, with Diclofenac Patch consistently demonstrating higher patient improvement percentages than Placebo across the range.*

FDA Label Image

Figure 3 (Diclofenac 04)

A line graph comparing the percent of patients improved versus percent improvement from baseline for Diclofenac Patch and Placebo. The graph shows two lines: one with filled circles for Diclofenac Patch, higher on the chart indicating better improvement, and one with open squares for Placebo, showing lower improvement across the baseline percentages.*

FDA Label Image

Figure 4 (Diclofenac 05)

A line graph comparing the percent of patients improved versus percent improvement from baseline for Diclofenac Patch and placebo. The graph shows two trend lines, with the Diclofenac Patch line consistently above the placebo, indicating higher patient improvement percentages across increasing improvement levels.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.